J&J Unit Faces 1st Morcellator Suit Since FDA Warning
A Johnson & Johnson unit on Thursday was hit with the first suit over its morcellator product used in a now controversial uterine fibroid removal procedure that the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article